154 related articles for article (PubMed ID: 38013124)
21. Solution speciation and human serum protein binding of indium(III) complexes of 8-hydroxyquinoline, deferiprone and maltol.
Dömötör O; Keppler BK; Enyedy ÉA
J Biol Inorg Chem; 2022 Apr; 27(3):315-328. PubMed ID: 35243522
[TBL] [Abstract][Full Text] [Related]
22. Buffer and pH effects on propranolol binding by human albumin and alpha 1-acid glycoprotein.
Ravis WR; Parsons DL; Wang SJ
J Pharm Pharmacol; 1988 Jul; 40(7):459-63. PubMed ID: 2904983
[TBL] [Abstract][Full Text] [Related]
23. Erdafitinib: A novel therapy for FGFR-mutated urothelial cancer.
Roubal K; Myint ZW; Kolesar JM
Am J Health Syst Pharm; 2020 Feb; 77(5):346-351. PubMed ID: 32073123
[TBL] [Abstract][Full Text] [Related]
24. Chebulinic and chebulagic acid binding with serum proteins: biophysical and molecular docking approach.
Yeggoni DP; Meti M; Subramanyam R
J Biomol Struct Dyn; 2023 Jun; 41(9):4024-4039. PubMed ID: 35403561
[TBL] [Abstract][Full Text] [Related]
25. In vitro plasma protein binding and aqueous aggregation behavior of astaxanthin dilysinate tetrahydrochloride.
Zsila F; Fitos I; Bikádi Z; Simonyi M; Jackson HL; Lockwood SF
Bioorg Med Chem Lett; 2004 Nov; 14(21):5357-66. PubMed ID: 15454227
[TBL] [Abstract][Full Text] [Related]
26. Spectroscopic Studies of Quinobenzothiazine Derivative in Terms of the In Vitro Interaction with Selected Human Plasma Proteins: Part 2.
Owczarzy A; Rogóż W; Kulig K; Pożycka J; Zięba A; Maciążek-Jurczyk M
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677755
[TBL] [Abstract][Full Text] [Related]
27. Interaction of Blenoxane and Congeners Bleomycins A2 and B2 with Human Plasma Proteins Using Circular Dichroism Spectroscopy.
Longo E; Siligardi G; Hussain R
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686404
[TBL] [Abstract][Full Text] [Related]
28. FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.
Hibi M; Kaneda H; Tanizaki J; Sakai K; Togashi Y; Terashima M; De Velasco MA; Fujita Y; Banno E; Nakamura Y; Takeda M; Ito A; Mitsudomi T; Nakagawa K; Okamoto I; Nishio K
Cancer Sci; 2016 Nov; 107(11):1667-1676. PubMed ID: 27581340
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxicity and comparative binding mechanism of piperine with human serum albumin and α-1-acid glycoprotein.
Yeggoni DP; Rachamallu A; Kallubai M; Subramanyam R
J Biomol Struct Dyn; 2015; 33(6):1336-51. PubMed ID: 25054206
[TBL] [Abstract][Full Text] [Related]
30. Characterization of basic drug-human serum protein interactions by capillary electrophoresis.
Martínez-Gómez MA; Sagrado S; Villanueva-Camañas RM; Medina-Hernández MJ
Electrophoresis; 2006 Sep; 27(17):3410-9. PubMed ID: 16944456
[TBL] [Abstract][Full Text] [Related]
31. Stereoselective protein binding of tetrahydropalmatine enantiomers in human plasma, HSA, and AGP, but not in rat plasma.
Sun DL; Huang SD; Wu PS; Li J; Ye YJ; Jiang HD
Chirality; 2010 Jun; 22(6):618-23. PubMed ID: 19927376
[TBL] [Abstract][Full Text] [Related]
32. Potential use of Cypridina luciferin for quantifying alpha 1-acid glycoprotein in human serum.
Kanie S; Mitani Y
Anal Sci; 2022 Dec; 38(12):1555-1562. PubMed ID: 36205879
[TBL] [Abstract][Full Text] [Related]
33. Comparative binding studies of bacosine with human serum albumin and α-1-acid glycoprotein biophysical evaluation and computational approach.
Yeggoni DP; Rachamallu A; Subramanyam R
J Pharm Biomed Anal; 2022 Feb; 209():114478. PubMed ID: 34894460
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of ponatinib in vitro effect in three canine mast cell tumor cell lines expressing FGFR-1, PDGFR-α, and VEGFR-2.
Fisher CJ; Lejeune AT; Dark MJ; Hernandez OM; Shiomitsu K
Vet J; 2021 Mar; 269():105621. PubMed ID: 33593493
[TBL] [Abstract][Full Text] [Related]
35. Investigation of the retention behavior of structurally diverse drugs on alpha(1) acid glycoprotein column: insight on the molecular factors involved and correlation with protein binding data.
Chrysanthakopoulos M; Vallianatou T; Giaginis C; Tsantili-Kakoulidou A
Eur J Pharm Sci; 2014 Aug; 60():24-31. PubMed ID: 24800938
[TBL] [Abstract][Full Text] [Related]
36. Measurement of drug-protein binding by immobilized human serum albumin-HPLC and comparison with ultrafiltration.
Singh SS; Mehta J
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 834(1-2):108-16. PubMed ID: 16567134
[TBL] [Abstract][Full Text] [Related]
37. Modification of a PAMPA model to predict passive gastrointestinal absorption and plasma protein binding.
Bujard A; Voirol H; Carrupt PA; Schappler J
Eur J Pharm Sci; 2015 Sep; 77():273-8. PubMed ID: 26118348
[TBL] [Abstract][Full Text] [Related]
38. Binding studies based on ultrafast affinity extraction and single- or two-column systems: Interactions of second- and third-generation sulfonylurea drugs with normal or glycated human serum albumin.
Yang B; Zheng X; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Dec; 1102-1103():8-16. PubMed ID: 30366211
[TBL] [Abstract][Full Text] [Related]
39. Gambogenic acid inhibits fibroblast growth factor receptor signaling pathway in erlotinib-resistant non-small-cell lung cancer and suppresses patient-derived xenograft growth.
Xu L; Meng X; Xu N; Fu W; Tan H; Zhang L; Zhou Q; Qian J; Tu S; Li X; Lao Y; Xu H
Cell Death Dis; 2018 Feb; 9(3):262. PubMed ID: 29449529
[TBL] [Abstract][Full Text] [Related]
40. Imatinib binding to human serum albumin modulates heme association and reactivity.
Di Muzio E; Polticelli F; Trezza V; Fanali G; Fasano M; Ascenzi P
Arch Biochem Biophys; 2014 Oct; 560():100-12. PubMed ID: 25057771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
